Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
22m agoTempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
1h agoFaraday Future Announces Strategic Partnership Between FF AI-Robotics and Boston International Business School to Launch the BIBS–FF AI Robotics Institute, the First Industry-Driven Physical AI and Robotics Institute in the United States
2h agoFrom Funan to the World Stage, Homegrown mc.2 Acquired by Global Leader Hunter Douglas After Two Decades of Consumer-Led Innovation
2h agoBOE, UNESCO introduce Asia-Pacific Science Club Network & 2026 Science Challenge
2h agoScorpio Tankers Inc. Prices Reopening of 1.75% Convertible Senior Notes due 2031 and Concurrent Stock Repurchase
Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc.

About

Pelthos Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 1 2026
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Apr 14 2026
Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
Apr 10 2026
Pelthos Therapeutics Announces CFO Transition
Mar 31 2026
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
Mar 19 2026
Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results

Community Chat

Ask AI

6ix6ixAIEvents